A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms

CONCLUSION: We validated the DIAMODIA criteria, as it effectively identified all monogenic diabetes patients (MODY cohort) and succeeded to differentiate T1DM from MODY patients. The creation of this new and effective tool is likely to facilitate the characterization and therapeutic management of patients with atypical diabetes, and promptly referring them for genetic testing which would markedly improve clinical care and counseling, as well.PMID:38523249 | DOI:10.4093/dmj.2023.0166

Source: Diabetes and Metabolism Journal - March 25, 2024 Category: Endocrinology Authors: Sophie Welsch Antoine Harvengta Paola Gallo Manon Martin Dominique Beckers Thierry Mouraux Nicole Seret Marie-Christine Lebrethon Raphael Helear Pascal Brouillard Miikka Vikkula Philippe A Lysy Source Type: research